Phase 3 Biotech Fund, LP
Phase 3 Biotech Fund, LP is a hedge fund based in Highlands Ranch, Colorado. According to its most recent Form D, filed Mar 16, 2020, the fund has sold $410,750 of interests to 4 investors since its first sale in Mar 2020. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include a Delaware limited liability company Phase 3 Biotech Fund GP, LLC; Gordon Andringa.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $410,750Cumulative sales reported on Form D
- Investors
- 4
- First sale
- Mar 2, 2020
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- a Delaware limited liability company Phase 3 Biotech Fund GP, LLC; Gordon Andringa
- Latest Form D
- Mar 16, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Phase 3 Biotech Fund, LP
What is the minimum investment for Phase 3 Biotech Fund, LP?
Phase 3 Biotech Fund, LP's latest Form D, filed Mar 16, 2020, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Phase 3 Biotech Fund, LP?
Phase 3 Biotech Fund, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Phase 3 Biotech Fund, LP raised?
Phase 3 Biotech Fund, LP reports $410,750 sold from 4 investors on its Form D filed Mar 16, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is Phase 3 Biotech Fund, LP based?
Phase 3 Biotech Fund, LP is based in Highlands Ranch, Colorado.
When did Phase 3 Biotech Fund, LP launch?
Phase 3 Biotech Fund, LP reports its first sale in Mar 2020.
Size compared with every hedge fund
Raised more than 13% of the 112 hedge funds based in Colorado, and more than 3% of all 10,144 that report sales.